The epidemic of esophageal adenocarcinoma

Gastroenterology Clinics of North America

Volumn 31, Issue 2, 2002, Pages 421-440

  El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EPIDEMIC; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; LOWER ESOPHAGUS SPHINCTER; REVIEW; AGE DISTRIBUTION; CARDIA; COHORT ANALYSIS; ESOPHAGUS TUMOR; ETHNIC GROUP; HEALTH; INCIDENCE; PATHOLOGY; RACE; RISK FACTOR; STATISTICS; SURVIVAL RATE; UNITED STATES;

ADENOCARCINOMA; AGE DISTRIBUTION; CARDIA; COHORT STUDIES; DISEASE OUTBREAKS; ESOPHAGEAL NEOPLASMS; ETHNIC GROUPS; HUMAN; INCIDENCE; RACIAL STOCKS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; WORLD HEALTH; CONTINENTAL POPULATION GROUPS; HUMANS;

EID: 0036310792     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(02)00016-X     Document Type: Review

References (82)

1. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
2. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
3. The rising incidence of gastric cardia cancer
4. Evaluating gastric cancer misclassification: A potential explanation for the rise in cardia cancer incidence
5. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
6. Epidemiological difference between adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia
7. Causative factors in the etiology of peptic ulcer disease become effective before the age of 15
8. Period effects, generation effects, and age effects in peptic ulcer mortality
9. Opposing time trends between esophagitis and peptic ulcer disease
10. Gastric carcinoma
11. Characteristics of intestinal metaplasia in the gastric cardia
12. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
13. Intestinal metaplasia of the gastric cardia
14. Symptomatic gastroesophageal reflux disease as a risk factor for esophageal adenocarcinoma
15. Association between body mass and adenocarcinoma of the esophagus and gastric cardia
16. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction
17. Trends in incidence rates of adenocarcinoma of the esophagus and gastric cardia in New Zealand, 1978-1992
18. Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries
19. Adenocarcinoma of the esophagus and Barrett's esophagus: A population-based study
20. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites
21. Epidemiology of adenocarcinoma and squamous cell carcinoma of the esophagus
22. Esophageal and gastric cancer in Scotland 1960-90
23. The epidemiology of esophageal adenocarcinoma: Has the cancer of the gastric cardia an influence on the rising rates of esophageal adenocarcinoma?
24. Inverse association between intake of cereal fiber and risk of gastric cardia cancer
25. Temporal trends in survival of patients with esophageal adenocarcinoma
26. Barrett's esophagus
27. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings
28. Secular trend in the epidemiology and outcome of Barrett's esophagus in Olmsted County, Minnesota
29. Comparison of incidence and resection rates in patients with esophageal squamous cell carcinoma and adenocarcinoma
30. Barrett's esophagus: Its prevalence and association with adenocarcinoma in patients with gastroesophageal reflux
31. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus
32. The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia
33. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus
34. Risk factors for Barrett's esophagus in community-based practice
35. Gastroesophageal reflux and Barrett's esophagus in adults born with esophageal atresia
36. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma
37. Gastroesophageal reflux disease in monozygotic and dizygotic twins
38. Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14
39. Familial Barrett's esophagus: Is the key erosive esophagitis in young adults?
40. Barrett's esophagus: Prevalence in relatives with and without frequent symptoms
41. Epidemiology of gastroesophageal reflux disease
42. Body mass index and risk of adenocarcinoma of the esophagus and gastric cardia
43. Overweight, but not dietary fat intake, increases the risk of gastroesophageal disease hospitalization: The NHANES I epidemiologic follow-up study
44. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population
45. Risk factors associated with symptoms of gastroesophageal reflux
46. The prevalence of symptoms suggestive of esophageal disorders
47. The spread of the obesity epidemic in the United States, 1991-1998
48. Obesity and gastroesophageal reflux disease: Is there a relationship?
49. Gastroesophageal reflux in obese patients is not reduced by weight reduction
50. Adenocarcinoma of the esophagus: Role of obesity and diet
51. Incidence trends in esophageal and proximal gastric carcinoma in Victoria
52. Adenocarcinoma of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors
53. Increasing concerns about chronic proton pump inhibitor use
54. Antioxidants and cancers of the esophagus and gastric cardia
55. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus
56. Tobacco, alcohol, and socioeconomic status and adenocarcinoma of the esophagus and gastric cardia
57. The role of tobacco, snuff and alcohol use in the etiology of cancer of the esophagus and gastric cardia
58. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma
59. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma
60. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
61. Helicobacter pylori in the pathogenesis of duodenal ulcer and gastric cancer: A model
62. Helicobacter pylori infection in patients with duodenal ulcer disease
63. H. pylori and CagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications
64. Effect of a Campylobacter pylori protein on acid secretion by the parietal cells
65. Helicobacter pylori and gastric acid: Biological and therapeutic implications
66. Correlative study: Gastric secretion and histology
67. Helicobacter pylori reinfection with identical organisms: Transmission by the patients' spouses
68. Corpus gastritis is protective against reflux esophagitis
69. + strains of Helicobacter pylori infection and the risk of esophageal and gastric cardia combined
70. Prevalence of Helicobacter pylori in subtypes of gastric cancer
71. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's esophagus or Barrett's adenocarcinoma
72. Risk of esophageal and gastric adenocarcinoma in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux
73. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
74. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis
75. Helicobacter pylori infection and chronic gastric hyposecretion
76. Curing Helicobacter pylori infection in duodenal ulcer patients may provoke reflux esophagitis
77. Ethnic variation in gastroesophageal malignancies
78. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: A case-control study
79. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma